Quarterly report pursuant to Section 13 or 15(d)

Note 2 - Selected Balance Sheet Data (Tables)

v3.6.0.2
Note 2 - Selected Balance Sheet Data (Tables)
 6 Months Ended
Dec. 31, 2016
Notes Tables  
Schedule of Inventory, Current [Table Text Block]
 
 
December 31,
 
 
June 30,
 
 
 
2016
 
 
2016
 
Raw materials
   $
22,201
     $
22,963
  
Finished goods
    
43,888
      
34,139
  
Inventories, net
   $
66,089
     $
57,102
  
Property, Plant and Equipment [Table Text Block]
 
 
December 31,
 
 
June 30,
 
 
 
2016
 
 
2016
 
                 
Land
   $
6,270
     $
6,270
  
Buildings and improvements
    
157,337
      
157,963
  
Machinery and equipment
    
90,033
      
82,018
  
Property and equipment, cost
    
253,640
      
246,251
  
Accumulated depreciation and amortization
    
(121,688
)
    
(113,889
)
Property and equipment, net
   $
131,952
     $
132,362
  
Schedule of Intangible Assets and Goodwill [Table Text Block]
 
 
December 31,
 
 
June 30,
 
 
 
2016
 
 
2016
 
                 
Developed technology
   $
232,557
     $
120,611
  
Trade names
    
81,554
      
63,706
  
Customer relationships
    
272,082
      
191,118
  
Non-compete agreements
    
3,455
      
3,284
  
Intangible assets
    
589,648
      
378,719
  
Accumulated amortization
    
(96,106
)
    
(75,595
)
Net amortizable intangible asset
    
493,542
      
303,124
  
In process research and development
    
-
      
7,400
  
Intangible assets, net
   $
493,542
     $
310,524
  
Schedule of Finite-Lived Intangible Assets [Table Text Block]
Beginning balance
   $
310,524
  
Acquisitions (Note 3)
    
208,869
  
Amortization expense
    
(21,815
)
Currency translation
    
(4,036
)
Ending balance
   $
493,542
  
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]
2017
   $
23,193
  
2018
    
46,255
  
2019
    
45,510
  
2020
    
44,869
  
2021
    
44,528
  
2022
    
42,930
  
Thereafter
    
246,257
  
Total
   $
493,542
  
Schedule of Goodwill [Table Text Block]
   
Biotechnology
    
Diagnostics
    
Protein Platforms
    
Total
  
Beginning balance
   $
105,181
     $
105,729
     $
219,972
     $
430,882
  
Acquisitions (Note 3)
    
130,587
      
 
      
 
      
130,587
  
Prior year acquisitions (Note 3)
    
 
      
 
      
1,809
      
1,809
  
Currency translation
    
(2,580
)
    
 
      
(2,967
)
    
(5,547
)
Ending balance
   $
233,188
     $
105,729
     $
218,814
     $
557,731
  
Schedule of Other Assets, Noncurrent [Table Text Block]
 
 
December 31,
 
 
June 30,
 
 
 
2016
 
 
2016
 
Investments
   $
40,000
     $
-
  
Other
    
2,694
      
1,922
  
    $
42,694
     $
1,922